Search

Search Constraints

You searched for: Author/Creator John, Samuel

Search Results

3. Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells. Issue 2 (7th August 2020)

4. Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL. Issue 9 (20th March 2022)